Manorama Industries Ltd
Manorama Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #9 of 31 in Food Products
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
The company began FY27 on a very healthy note, with Q1 performance establishing a strong run rate for the year. The company has demonstrated consistent strong performance over 20-25 quarters, indicating stable growth.
From Manorama Industries Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- The company began FY27 on a very healthy note, with Q1 performance establishing a strong run rate for the year.
- Expectation of healthy top-line growth in FY27 supported by capacity ramp-up and debottlenecking.
- Focus on improving utilization of plants, targeting around 80%-85% utilization post-debottlenecking.
- New capex plans include expanding solvent fractionation and refinery capacity, along with backward integration in Burkina Faso, expected to support growth into FY28 and beyond.
- Additional incremental capacity of approximately 4,500 tons from debottlenecking expected to come online in FY27 Q3, increasing total capacity to around 52,000 tons per annum.
2 more points from Manorama Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Manorama Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Manorama Industries has a proposed capex plan of approximately INR 460 crores, expected to be commissioned by Q3 FY28, with full impact visible in FY29.
- Capex includes expanding solvent fractionation capacity, refinery capacity in India, and backward integration project in Burkina Faso.
- Burkina Faso facility capex is around INR 120-130 crores; the balance is for Indian projects.
- Debottlenecking capacity expansion of 4,500 MTPA during FY27 costing around INR 5-6 crores.
- Total capex spending planned for FY27 is around INR 225-250 crores, with about INR 70 crores already spent.
2 more points from Manorama Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Manorama Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Manorama Industries Ltd said on order book & pipeline — free account, 30 seconds.
Manorama Industries Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹382 Cr, net profit ₹60 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Manorama Indust.'s management said in earlier quarters
Others in Food Products this season
- Wardwizard Foods (Q1 FY27)
Revenue for Q1 FY27 (June 2026 quarter) is ₹17.03 Cr, up from ₹13.20 Cr in Q1 FY26, reflecting a strong year-on-year growth. Key investor presentation takeaways
- Chemkart India (Q1 FY27)
Revenue from operations for Apr–Jun FY27 reported at INR 99.60 crore (INR 9,960.22 lakhs). Key investor presentation takeaways from Chemkart India Ltd's Q1 FY27
- Sheetal Cool (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Manorama Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Manorama Industries Ltd Q1 FY27 results?
The company began FY27 on a very healthy note, with Q1 performance establishing a strong run rate for the year. The company has demonstrated consistent strong performance over 20-25 quarters, indicating stable growth.
What is Manorama Industries Ltd share price analysis?
Manorama Industries Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 45.7 with a market cap of ₹12,065 Cr. Investors should review the full earnings analysis for detailed insights.
Is Manorama Industries Ltd planning capital expenditure?
Manorama Industries has a proposed capex plan of approximately INR 460 crores, expected to be commissioned by Q3 FY28, with full impact visible in FY29.
Keep Manorama Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.